251 related articles for article (PubMed ID: 23267110)
1. Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model.
Shi TJ; Zhang MD; Zeberg H; Nilsson J; Grünler J; Liu SX; Xiang Q; Persson J; Fried KJ; Catrina SB; Watanabe M; Arhem P; Brismar K; Hökfelt TG
Proc Natl Acad Sci U S A; 2013 Jan; 110(2):690-5. PubMed ID: 23267110
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes.
Zhang YP; Eber A; Yuan Y; Yang Z; Rodriguez Y; Levitt RC; Takacs P; Candiotti KA
Anesthesiology; 2013 Apr; 118(4):945-54. PubMed ID: 23334664
[TBL] [Abstract][Full Text] [Related]
3. Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10.
Zhang YP; Song CY; Yuan Y; Eber A; Rodriguez Y; Levitt RC; Takacs P; Yang Z; Goldberg R; Candiotti KA
Neurobiol Dis; 2013 Oct; 58():169-78. PubMed ID: 23684663
[TBL] [Abstract][Full Text] [Related]
4. Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes.
Sourris KC; Harcourt BE; Tang PH; Morley AL; Huynh K; Penfold SA; Coughlan MT; Cooper ME; Nguyen TV; Ritchie RH; Forbes JM
Free Radic Biol Med; 2012 Feb; 52(3):716-723. PubMed ID: 22172526
[TBL] [Abstract][Full Text] [Related]
5. Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes.
Hinder LM; Vivekanandan-Giri A; McLean LL; Pennathur S; Feldman EL
J Endocrinol; 2013 Jan; 216(1):1-11. PubMed ID: 23086140
[TBL] [Abstract][Full Text] [Related]
6. p38 mediates mechanical allodynia in a mouse model of type 2 diabetes.
Cheng HT; Dauch JR; Oh SS; Hayes JM; Hong Y; Feldman EL
Mol Pain; 2010 May; 6():28. PubMed ID: 20482876
[TBL] [Abstract][Full Text] [Related]
7. Taurine reverses neurological and neurovascular deficits in Zucker diabetic fatty rats.
Li F; Abatan OI; Kim H; Burnett D; Larkin D; Obrosova IG; Stevens MJ
Neurobiol Dis; 2006 Jun; 22(3):669-76. PubMed ID: 16624563
[TBL] [Abstract][Full Text] [Related]
8. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
[TBL] [Abstract][Full Text] [Related]
9. Proteomic quantitative study of dorsal root ganglia and sciatic nerve in type 2 diabetic mice.
Leal-Julià M; Vilches JJ; Onieva A; Verdés S; Sánchez Á; Chillón M; Navarro X; Bosch A
Mol Metab; 2022 Jan; 55():101408. PubMed ID: 34856394
[TBL] [Abstract][Full Text] [Related]
10. SP6616 as a Kv2.1 inhibitor efficiently ameliorates peripheral neuropathy in diabetic mice.
Zhu X; Chen Y; Xu X; Xu X; Lu Y; Huang X; Zhou J; Hu L; Wang J; Shen X
EBioMedicine; 2020 Nov; 61():103061. PubMed ID: 33096484
[TBL] [Abstract][Full Text] [Related]
11. Extracellular signal-regulated protein kinase activation in spinal cord contributes to pain hypersensitivity in a mouse model of type 2 diabetes.
Xu X; Chen H; Ling BY; Xu L; Cao H; Zhang YQ
Neurosci Bull; 2014 Feb; 30(1):53-66. PubMed ID: 24194231
[TBL] [Abstract][Full Text] [Related]
12. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.
Vareniuk I; Pavlov IA; Drel VR; Lyzogubov VV; Ilnytska O; Bell SR; Tibrewala J; Groves JT; Obrosova IG
Exp Neurol; 2007 Jun; 205(2):425-36. PubMed ID: 17475250
[TBL] [Abstract][Full Text] [Related]
13. Altered distribution of juxtaparanodal kv1.2 subunits mediates peripheral nerve hyperexcitability in type 2 diabetes mellitus.
Zenker J; Poirot O; de Preux Charles AS; Arnaud E; Médard JJ; Lacroix C; Kuntzer T; Chrast R
J Neurosci; 2012 May; 32(22):7493-8. PubMed ID: 22649228
[TBL] [Abstract][Full Text] [Related]
14. Alpha-lipoic acid and coenzyme Q10 combination ameliorates experimental diabetic neuropathy by modulating oxidative stress and apoptosis.
Sadeghiyan Galeshkalami N; Abdollahi M; Najafi R; Baeeri M; Jamshidzade A; Falak R; Davoodzadeh Gholami M; Hassanzadeh G; Mokhtari T; Hassani S; Rahimifard M; Hosseini A
Life Sci; 2019 Jan; 216():101-110. PubMed ID: 30393023
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes.
Huynh K; Kiriazis H; Du XJ; Love JE; Jandeleit-Dahm KA; Forbes JM; McMullen JR; Ritchie RH
Diabetologia; 2012 May; 55(5):1544-53. PubMed ID: 22374176
[TBL] [Abstract][Full Text] [Related]
16. miR-125a-5p in astrocytes attenuates peripheral neuropathy in type 2 diabetic mice through targeting TRAF6.
Kasimu A; Apizi X; Talifujiang D; Ma X; Fang L; Zhou X
Endocrinol Diabetes Nutr (Engl Ed); 2022 Jan; 69(1):43-51. PubMed ID: 35232559
[TBL] [Abstract][Full Text] [Related]
17. Sodium channel Nav1.6 is up-regulated in the dorsal root ganglia in a mouse model of type 2 diabetes.
Ren YS; Qian NS; Tang Y; Liao YH; Yang YL; Dou KF; Toi M
Brain Res Bull; 2012 Feb; 87(2-3):244-9. PubMed ID: 22075254
[TBL] [Abstract][Full Text] [Related]
18. miR-146a mediates thymosin β4 induced neurovascular remodeling of diabetic peripheral neuropathy in type-II diabetic mice.
Wang L; Chopp M; Lu X; Szalad A; Jia L; Liu XS; Wu KH; Lu M; Zhang ZG
Brain Res; 2019 Mar; 1707():198-207. PubMed ID: 30500399
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.
Wang L; Chopp M; Szalad A; Liu Z; Bolz M; Alvarez FM; Lu M; Zhang L; Cui Y; Zhang RL; Zhang ZG
Neuroscience; 2011 Oct; 193():399-410. PubMed ID: 21820491
[TBL] [Abstract][Full Text] [Related]
20. Altered sciatic nerve fiber morphology and endoneural microvessels in mouse models relevant for obesity, peripheral diabetic polyneuropathy, and the metabolic syndrome.
Nowicki M; Kosacka J; Serke H; Blüher M; Spanel-Borowski K
J Neurosci Res; 2012 Jan; 90(1):122-31. PubMed ID: 21919033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
